Breast Cancer Clinical Trials in Kansas City, Kansas

5 studies are recruiting for breast cancer in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

   This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with es…

   Stage

   Phase 3

   Ages

   18 to 60

   Site

   University of Kansas Cancer Center, Kansas City, Kansas

   Locations

   1261 in total

   Run by

   NRG Oncology

   See if you can join NCT05879926 on ClinicalTrials.gov

2. Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

   This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   AMR Kansas City Oncology, Kansas City, Kansas

   Locations

   79 in total

   Run by

   BriaCell Therapeutics Corporation

   See if you can join NCT06072612 on ClinicalTrials.gov

3. Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

   PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

   Stage

   Not phased

   Ages

   Any age

   Site

   KCCC West, Kansas City, Kansas

   Locations

   11 in total

   Run by

   University of Kansas Medical Center

   See if you can join NCT02302742 on ClinicalTrials.gov

4. Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

   This is a randomized phase II study to evaluate the pathological complete response (pCR) rate with two neoadjuvant regimens (Docetaxel+Carboplatin+Herceptin/Perjeta and Docetaxel+Herceptin/Perjeta) in HER2 amplified/positive early breast cancer.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   The University of Kansas Cancer Center - Westwood, Kansas City, Kansas

   Locations

   8 in total

   Run by

   University of Kansas Medical Center

   See if you can join NCT07220135 on ClinicalTrials.gov

5. High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

   The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.

   Stage

   Not phased

   Ages

   30 to 65

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Run by

   Carol Fabian, MD

   See if you can join NCT00291096 on ClinicalTrials.gov